Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
59 hedge funds and large institutions have $97.6M invested in Ampio Pharmaceuticals Inc. in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 12 closing their positions.
222% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 9
3% more capital invested
Capital invested by funds: $94.5M → $97.6M (+$3.17M)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
2% less funds holding
Funds holding: 60 → 59 (-1)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
52% less call options, than puts
Call options by funds: $1.16M | Put options by funds: $2.44M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
Talkot Capital
Sausalito,
California
|
+$1.46M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.05M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$842K |
| 4 |
State Street
Boston,
Massachusetts
|
+$603K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$468K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$9.94M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.65M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.19M |
| 4 |
HT
HAP Trading
New York
|
-$1.35M |
| 5 |
Jane Street
New York
|
-$575K |
AMPE Hedge Fund Activity: Q4 2013 in Review
59 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2013, worth a combined $97.6M — up 3.4% from $94.5M a quarter earlier.
Fund positioning in AMPE was balanced in Q4 2013: 12 funds opened new positions, 12 closed out, 29 added to existing stakes and 9 trimmed.
The largest buyer was Talkot Capital, adding an estimated $1.46M. The largest seller was RA Capital Management, exiting entirely with an estimated $9.94M sold.
- 59 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2013, down from 60 in Q3 2013.
- Funds reported $97.6M of Ampio Pharmaceuticals Inc. stock for Q4 2013, up 3.4% quarter-over-quarter.
- 12 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2013 and 12 closed out, a net change of 0 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2013 was Talkot Capital, an estimated $1.46M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2013 was RA Capital Management, an estimated $9.94M sold.
Based on aggregated 13F filings for Q4 2013.